首页|期刊导航|癌症（英文版）|Hepatic artery infusion chemotherapy using mFOLFOX versus transarterial chemoembolization for massive unresectable hepatocellular carcinoma:a prospective non-randomized study

Hepatic artery infusion chemotherapy using mFOLFOX versus transarterial chemoembolization for massive unresectable hepatocellular carcinoma:a prospective non-randomized study

Min-Ke He Yong Le Qi-Jiong Li Zi-Shan Yu Shao-Hua Li Wei Wei Rong-Ping Guo Ming Shi

癌症（英文版）2017，Vol.36Issue(12)：704-711,8.

癌症（英文版）2017，Vol.36Issue(12)：704-711,8.DOI:10.1186/s40880-017-0251-2

Hepatic artery infusion chemotherapy using mFOLFOX versus transarterial chemoembolization for massive unresectable hepatocellular carcinoma:a prospective non-randomized study

Min-Ke He ¹Yong Le ¹Qi-Jiong Li ¹Zi-Shan Yu ¹Shao-Hua Li ¹Wei Wei ¹Rong-Ping Guo ¹Ming Shi¹

作者信息

1. Department of Hepatobiliary Oncology,State Key Laboratory of Oncology in South China,Collaborative Innovation Center for Cancer Medicine,Sun Yat-sen University Cancer Center,651 Dongfeng Road East,Guangzhou 510060,Guangdong,P.R.China
折叠

摘要

关键词

Hepatocellular carcinoma/Hepatic artery infusion chemotherapy/Transarterial chemoembolization/mFOLFOX

Key words

Hepatocellular carcinoma/Hepatic artery infusion chemotherapy/Transarterial chemoembolization/mFOLFOX

引用本文复制引用

Min-Ke He,Yong Le,Qi-Jiong Li,Zi-Shan Yu,Shao-Hua Li,Wei Wei,Rong-Ping Guo,Ming Shi..Hepatic artery infusion chemotherapy using mFOLFOX versus transarterial chemoembolization for massive unresectable hepatocellular carcinoma:a prospective non-randomized study[J].癌症（英文版）,2017,36(12):704-711,8.

基金项目

This work was supported by the National Natural Science Foundation of China (No. 81625017 and No. 81572385) and the Fundamental Research Funds for the Central Universities of China (No. 16ykjc36). （No. 81625017 and No. 81572385）

癌症（英文版）

OACSCDCSTPCDSCI

ISSN：1000-467X

访问量0

下载量0

段落导航